INS and type 2 diabetes mellitus: A positive allosteric modulator of M3 muscarinic receptors has been shown to restore glucose homeostasis in diabetic, glucose intolerant mice by promoting insulin secretion and may be a target for future clinical treatment of T2DM [138].